Synta Pharmaceuticals, a biotech developing drugs for chronic inflammatory diseases and cancer, filed for an IPO on Wednesday. The Lexington, MA-based company filed for an IPO once before in January 2005, but withdrew six months later citing unfavorable market conditions. Bear Stearns and Lehman Brothers are set to manage the deal. Terms and timing have yet to be announced.
